Jordi Mata-Fink, PhD, cofounder of Gate Bioscience, joins Vineeta Agarwala and Ben Portney of a16z Bio + Health.
In this episode, Jordi discusses how he and his cofounders are working to commercialize a novel class of therapeutics, termed “molecular gates.” His company, Gate, is working to exploit a previously uncharted avenue in cell biology—the secretory translocon—for therapeutic intervention. This approach has the potential to combat diseases otherwise resistant to existing therapeutics.
Jordi also imparts valuable insights on the power of platform-based problem-solving and team building.
Vineeta Agarwala is a general partner on the Bio + Health team at Andreessen Horowitz, focused on biotech, digital health, and life sciences tools/diagnostics.
Ben Portney is an investing partner on the Bio + Health team.
Kris Tatiossian is the content lead, life sciences, on the Bio + Health team.
Olivia Webb is the editorial lead, healthcare, on the Bio + Health team.
Between the growing ability to engineer biology for therapeutics, and the integration of tech into how patients receive care, bio and health are fundamentally changing the world. Join the team at a16z and host Olivia Webb as they discuss these transformations with scientists, builders, and leaders.